These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 5593256)
1. [On the problem of fixed extrapyramidal disorders following prolonged use of neuroleptics]. Krystof J; Kajzer J Psychiatr Pol; 1967; 1(3):289-93. PubMed ID: 5593256 [No Abstract] [Full Text] [Related]
2. [Symptoms of the extrapyramidal syndrome during maintenence therapy with neuroleptic drugs]. Sujecka-Szymkiewicz H Psychiatr Pol; 1967; 1(1):79-84. PubMed ID: 4876412 [No Abstract] [Full Text] [Related]
3. [On the problem of persistent extrapyramidal hyperkinesia following prolonged use of neuroleptics]. Degkwitz R; Binsack KF; Herkert H; Luxenburger O; Wenzel W Nervenarzt; 1967 Apr; 38(4):170-4. PubMed ID: 4382352 [No Abstract] [Full Text] [Related]
4. The prevalence of tardive dyskinesias in mental hospital patients. Fann WE; Davis JM; Janowsky DS Dis Nerv Syst; 1972 Mar; 33(3):182-6. PubMed ID: 5022453 [No Abstract] [Full Text] [Related]
5. [Study of extrapyramidal manifestations induced by neuroleptics]. Bordeleau JM; Tétreault L Rev Can Biol; 1972; 31():Suppl:247-53. PubMed ID: 4403291 [No Abstract] [Full Text] [Related]
6. Extra pyramidal manifestations following phenothiazines therapy. Report of 10 cases with review of Indian literature. Mittal MM; Gupta SK; Misra RC J Assoc Physicians India; 1970 Aug; 18(8):691-6. PubMed ID: 5480839 [No Abstract] [Full Text] [Related]
7. Tardive dyskinesia in patients treated with major neuroleptics: a review of the literature. Crane GE Am J Psychiatry; 1968 Feb; 124(8):Suppl:40-8. PubMed ID: 4865731 [No Abstract] [Full Text] [Related]
8. [Extrapyramidal symptoms during the use of neuroleptics]. Ditfurth HV Nervenarzt; 1967 Apr; 38(4):151-5. PubMed ID: 4382350 [No Abstract] [Full Text] [Related]
11. A survey of extrapyramidal manifestations in the inpatient population of a psychiatric hospital. Lehmann HE; Ban TA; Saxena BM Laval Med; 1970 Sep; 41(7):909-16. PubMed ID: 5509489 [No Abstract] [Full Text] [Related]
12. Taste sensitivity and the appearance of phenothiazine-tranquilizer induced extrapyramidal symptoms. Fischer R; Knopp W; Griffin F Arzneimittelforschung; 1965 Dec; 15(12):1379-82. PubMed ID: 5899813 [No Abstract] [Full Text] [Related]
13. Phenothiazine toxicity in paediatric practice with three case reports. Bajpai PC; Sethi VK; Pathak AK; Tripathi TK Indian Pediatr; 1969 Jul; 6(7):470-5. PubMed ID: 5345025 [No Abstract] [Full Text] [Related]
15. A survey of extrapyramidal manifestations in patients attending an after care clinic of a psychiatric hospital. Guttman H; Lehmann HE; Ban TA Laval Med; 1970 Apr; 41(4):449-55. PubMed ID: 5515661 [No Abstract] [Full Text] [Related]
17. [Action of amantadine in extrapyramidal syndromes caused by neuroleptics]. Fanali A; Nardini M; Sorgona F Sist Nerv; 1970; 22(5):273-85. PubMed ID: 5514245 [No Abstract] [Full Text] [Related]
18. [The semiology of motor function disorders during treatment with neuroleptic drugs]. Fleĭs EP Zh Nevropatol Psikhiatr Im S S Korsakova; 1970; 70(12):1798-804. PubMed ID: 5511943 [No Abstract] [Full Text] [Related]
20. [On the problem of the terminal extrapyramidal hyperkineses as observed in 1600 patients during long-term therapy with neuroleptics]. Degkwitz R; Wenzel W; Binsack KF; Herkert H; Luxenburger O Arzneimittelforschung; 1966 Feb; 16(2):276-9. PubMed ID: 4861657 [No Abstract] [Full Text] [Related] [Next] [New Search]